TRCT
MDVX

Tower Research Capital (TRC)’s Medovex Corp. Common Stock MDVX Stock Holding History

Tower Research Capital (TRC)’s Portfolio MDVX Stock Details MDVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-828
Closed -$1K – 4842
2016
Q3 		$1K Buy
828
+34
+4% +$48 ﹤0.01% 3483
2016
Q2 		$1K Buy
+794
New +$1.08K ﹤0.01% 4317
2015
Q4 		– Sell
-819
Closed -$1.27K – 5478
2015
Q3 		$2K Sell
819
-997
-55% -$2.94K ﹤0.01% 3496
2015
Q2 		$7K Buy
1,816
+930
+105% +$3.67K ﹤0.01% 3053
2015
Q1 		$4K Buy
+886
New +$4.21K ﹤0.01% 3477

Other funds holding MDVX

MIC
Meridian Investment Counsel Lafayette, California $466M AUM 42.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s MDVX Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of Medovex Corp. Common Stock (MDVX) in Q4 2016, closing a stake of 828 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in MDVX in Q1 2015 and held it in 5 quarters. The position peaked at $7K in Q2 2015. 9 funds tracked by Wall St. Rank hold MDVX as of Q4 2016.

  • Tower Research Capital (TRC) reported no remaining Medovex Corp. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 828 Medovex Corp. Common Stock shares in Q4 2016, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Medovex Corp. Common Stock in Q1 2015 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s Medovex Corp. Common Stock position peaked at $7K in Q2 2015.
  • 9 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.